{"id":51638,"date":"2021-10-18T04:30:33","date_gmt":"2021-10-18T09:30:33","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=topics&p=51638"},"modified":"2025-12-23T13:58:43","modified_gmt":"2025-12-23T18:58:43","slug":"invasive-crc-rate","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/","title":{"rendered":"Taux de d\u00e9tection de cancers colorectaux invasifs du programme"},"content":{"rendered":"

Pourquoi est-ce important?<\/strong> \u2013 Le taux de d\u00e9tection des cancers colorectaux invasifs chez les personnes subissant un d\u00e9pistage au sein des programmes permet d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ces programmes, au fil du temps. Les taux de d\u00e9tection d\u00e9pendent de nombreux facteurs, notamment la sensibilit\u00e9 du test de d\u00e9pistage et la capacit\u00e9 de fournir des proc\u00e9dures de suivi rapides et de haute qualit\u00e9 \u00e0 toutes les personnes ayant obtenu des r\u00e9sultats de d\u00e9pistage anormaux. Cet indicateur doit \u00e9galement \u00eatre corr\u00e9l\u00e9 avec la r\u00e9partition des stades des cancers d\u00e9tect\u00e9s au d\u00e9pistage<\/a>.<\/p>\n

D\u00e9finition de l\u2019indicateur<\/strong>\u00a0: nombre de personnes, sur\u00a01\u00a0000\u00a0personnes ayant particip\u00e9 au d\u00e9pistage, qui re\u00e7oivent un diagnostic de cancer colorectal, confirm\u00e9 par pathologie \u00e0 partir d\u2019une coloscopie de suivi, r\u00e9alis\u00e9e dans les six mois ayant suivi un r\u00e9sultat de test f\u00e9cal anormal, durant la p\u00e9riode de mesure<\/p>\n

Cible<\/strong>\u00a0: au moins deux cancers colorectaux invasifs d\u00e9tect\u00e9s pour\u00a01\u00a0000\u00a0personnes ayant particip\u00e9 au d\u00e9pistage<\/p>\n

Calcul de l\u2019indicateur<\/strong><\/p>\n

Num\u00e9rateur\u00a0: nombre de personnes atteintes d\u2019un cancer colorectal invasif, d\u00e9tect\u00e9 par pathologie r\u00e9alis\u00e9e \u00e0 partir d\u2019une coloscopie de suivi, effectu\u00e9e dans les six mois ayant suivi un r\u00e9sultat de test f\u00e9cal anormal, obtenu au cours de la p\u00e9riode de mesure<\/p>\n

D\u00e9nominateur\u00a0: nombre de personnes ayant subi avec succ\u00e8s un ou plusieurs tests f\u00e9caux dont les r\u00e9sultats ont \u00e9t\u00e9 trait\u00e9s par le laboratoire, au cours de la p\u00e9riode de mesure<\/p>\n

Comment la p\u00e9riode de 2017-2018 se compare-t-elle \u00e0 celle de 2013-2014?<\/strong> Comparativement aux donn\u00e9es du rapport sur le d\u00e9pistage du cancer colorectal pour 2013-2014, o\u00f9 1,0 \u00e0 7,7\u00a0cancers ont \u00e9t\u00e9 d\u00e9tect\u00e9s pour 1\u00a0000\u00a0d\u00e9pistages, le taux de d\u00e9tection du cancer colorectal invasif du programme est rest\u00e9 relativement stable dans la plupart des territoires et provinces en 2017-2018.<\/p>\n

Autres consid\u00e9rations<\/strong>\u00a0: dans le cadre de cet indicateur, on utilise les ann\u00e9es de d\u00e9pistage 2016 \u00e0\u00a02017, afin de laisser suffisamment de temps pour le suivi et pour le diagnostic.
\n<\/a><\/p>\n

Taux de d\u00e9tection (pour 1\u00a0000) d\u2019un cancer colorectal invasif gr\u00e2ce au d\u00e9pistage syst\u00e9matique chez les personnes \u00e2g\u00e9es de 50 \u00e0\u00a074\u00a0ans, par province et par territoire, pour les ann\u00e9es de d\u00e9pistage 2016 et\u00a02017<\/strong><\/h2>\n

\"diagramme<\/p>\n

Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

Le taux de d\u00e9tection de cancers invasifs variait de 1,1 % au Manitoba \u00e0 5,4 % \u00e0 Terre-Neuve-et-Labrador. La cible de deux cancers colorectaux ou plus d\u00e9tect\u00e9s pour 1 000 personnes ayant particip\u00e9 au d\u00e9pistage a \u00e9t\u00e9 atteinte dans 5 des 8 territoires de comp\u00e9tence ayant fourni des donn\u00e9es pour cet indicateur.
\n<\/a><\/p>\n

Taux de d\u00e9tection (pour 1\u00a0000) d\u2019un cancer colorectal invasif gr\u00e2ce au d\u00e9pistage syst\u00e9matique chez les personnes \u00e2g\u00e9es de\u00a050 \u00e0\u00a074\u00a0ans, par province et par territoire, par sexe, pour les ann\u00e9es de d\u00e9pistage 2016 et\u00a02017<\/strong><\/h2>\n

\"diagramme<\/p>\n

Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

Dans l\u2019ensemble des territoires de comp\u00e9tence, un plus grand nombre de cancers invasifs ont \u00e9t\u00e9 d\u00e9tect\u00e9s chez les hommes, par rapport aux femmes.
\n<\/a><\/p>\n

Taux de d\u00e9tection (pour 1\u00a0000) d\u2019un cancer colorectal invasif gr\u00e2ce au d\u00e9pistage syst\u00e9matique chez les personnes \u00e2g\u00e9es de 50 \u00e0\u00a074\u00a0ans, par province et par territoire, par groupe d\u2019\u00e2ge, pour les ann\u00e9es de d\u00e9pistage 2016 et\u00a02017<\/strong><\/h2>\n

\"diagramme<\/p>\n

Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

Un plus grand nombre de cancers invasifs ont \u00e9t\u00e9 d\u00e9tect\u00e9s parmi les groupes plus \u00e2g\u00e9s dans presque toutes les provinces, le taux de d\u00e9tection le plus \u00e9lev\u00e9 ayant \u00e9t\u00e9 de 11,4 % chez les 70 \u00e0 74 ans \u00e0 Terre-Neuve-et-Labrador. La probabilit\u00e9 de contracter un cancer colorectal augmente dans les groupes plus \u00e2g\u00e9s<\/a>, et on s\u2019attend \u00e0 ce que le d\u00e9pistage permette de d\u00e9tecter un plus grand nombre de cancers au sein de ces groupes.
\n<\/a><\/p>\n

Taux de d\u00e9tection (pour 1\u202f000) d\u2019un cancer colorectal invasif gr\u00e2ce au d\u00e9pistage syst\u00e9matique chez les personnes \u00e2g\u00e9es de\u202f50 \u00e0\u202f74\u202fans, par province et par territoire, pour les tests f\u00e9caux initiaux et subs\u00e9quents, pour les ann\u00e9es de d\u00e9pistage\u202f2016 et\u202f2017<\/h2>\n

\"diagramme<\/p>\n

Description textuelle et notes de bas de page<\/a><\/sub><\/p>\n

Dans l\u2019ensemble des territoires de comp\u00e9tence ayant fourni des donn\u00e9es, le taux de d\u00e9tection de cancers colorectaux invasifs \u00e9tait plus \u00e9lev\u00e9 pour les tests f\u00e9caux initiaux, par rapport aux tests f\u00e9caux subs\u00e9quents. Il s\u2019agit l\u00e0 d\u2019un r\u00e9sultat attendu; en effet, les d\u00e9pistages initiaux permettent de d\u00e9tecter tous les cancers que la personne a pu contracter jusqu\u2019\u00e0 la date de l\u2019examen, parfois depuis de nombreuses ann\u00e9es, tandis que les d\u00e9pistages subs\u00e9quents ne mettent en \u00e9vidence que les cancers qui sont devenus d\u00e9tectables depuis l\u2019examen de d\u00e9pistage pr\u00e9c\u00e9dent.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pourquoi est-ce important? \u2013 Le taux de d\u00e9tection des cancers colorectaux invasifs chez les personnes subissant un d\u00e9pistage au sein des programmes permet d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ces programmes, au fil du temps. Les taux de d\u00e9tection d\u00e9pendent de nombreux facteurs, notamment la sensibilit\u00e9 du test de d\u00e9pistage et la capacit\u00e9 de fournir des proc\u00e9dures de […]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":51630,"menu_order":3,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-51638","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"\nCanadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taux de d\u00e9tection de cancers colorectaux invasifs du programme - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Pourquoi est-ce important? \u2013 Le taux de d\u00e9tection des cancers colorectaux invasifs chez les personnes subissant un d\u00e9pistage au sein des programmes permet d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ces programmes, au fil du temps. Les taux de d\u00e9tection d\u00e9pendent de nombreux facteurs, notamment la sensibilit\u00e9 du test de d\u00e9pistage et la capacit\u00e9 de fournir des proc\u00e9dures de […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-23T18:58:43+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/\",\"name\":\"Taux de d\u00e9tection de cancers colorectaux invasifs du programme - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg\",\"datePublished\":\"2021-10-18T09:30:33+00:00\",\"dateModified\":\"2025-12-23T18:58:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg\",\"contentUrl\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/invasive-crc-rate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Indicateurs\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/colorectal-indicators-2017-2018\\\/indicators\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Taux de d\u00e9tection de cancers colorectaux invasifs du programme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/","og_locale":"fr_FR","og_type":"article","og_title":"Taux de d\u00e9tection de cancers colorectaux invasifs du programme - Canadian Partnership Against Cancer","og_description":"Pourquoi est-ce important? \u2013 Le taux de d\u00e9tection des cancers colorectaux invasifs chez les personnes subissant un d\u00e9pistage au sein des programmes permet d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ces programmes, au fil du temps. Les taux de d\u00e9tection d\u00e9pendent de nombreux facteurs, notamment la sensibilit\u00e9 du test de d\u00e9pistage et la capacit\u00e9 de fournir des proc\u00e9dures de […]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2025-12-23T18:58:43+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/","name":"Taux de d\u00e9tection de cancers colorectaux invasifs du programme - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/#primaryimage"},"image":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/#primaryimage"},"thumbnailUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg","datePublished":"2021-10-18T09:30:33+00:00","dateModified":"2025-12-23T18:58:43+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/#primaryimage","url":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg","contentUrl":"https:\/\/www.partnershipagainstcancer.ca\/wp-content\/uploads\/2021\/09\/CRC-Graph-11-invasive-by-jurisdiction-FR.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/invasive-crc-rate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer colorectal","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/"},{"@type":"ListItem","position":3,"name":"Indicateurs","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/colorectal-indicators-2017-2018\/indicators\/"},{"@type":"ListItem","position":4,"name":"Taux de d\u00e9tection de cancers colorectaux invasifs du programme"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/51630"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=51638"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=51638"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=51638"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=51638"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=51638"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=51638"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=51638"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=51638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}